Literature DB >> 2997937

"Adult T-cell leukemia/lymphoma" with bone demineralization.

T Ohuchida, H Nishitani, N Kamikawaji, Y Niho, T Ooiwa, K Matsuura.   

Abstract

Two patients with T-cell malignancy having radiographic manifestations of generalized and localized bone demineralization are reported. One, a 53-year-old man, had marked osteoporosis and severe hypercalcemia, but no clinical evidence of leukemia throughout his illness. At autopsy there was no definite evidence of bone involvement. Histologic proof was obtained from abdominal skin which revealed "adult T-cell leukemia/lymphoma (ATLL)." The second case, a 33-year-old man, complained of arthralgia in his hands and feet; radiographs showed severe localized demineralization and pathologic fractures. Specimens of his peripheral blood, cervical lymph nodes, and bone marrow revealed ATLL cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2997937     DOI: 10.1007/bf00355562

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  9 in total

1.  Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood. 1977;50(3):481-492.

Authors: 
Journal:  Blood       Date:  2016-12-15       Impact factor: 22.113

Review 2.  Skeletal manifestations of the lymphomas and leukemias.

Authors:  B L Pear
Journal:  Semin Roentgenol       Date:  1974-07       Impact factor: 0.800

3.  [Hypercalcemia in large cell lymphoma. Possible role of prostaglandins E2 (author's transl)].

Authors:  A Boissonnas; P Khalifa; D Sereni; C Mathiot; M C Vacher-Lavenu; A Hornych; G A Cremer; C Laroche
Journal:  Ann Med Interne (Paris)       Date:  1982

4.  Human T-cell leukemia virus (HTLV) in the United Kingdom.

Authors:  M F Greaves; W Verbi; R Tilley; T A Lister; J Habeshaw; H G Guo; C D Trainor; M Robert-Guroff; W Blattner; M Reitz
Journal:  Int J Cancer       Date:  1984-06-15       Impact factor: 7.396

5.  Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease.

Authors:  M Yoshida; I Miyoshi; Y Hinuma
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

6.  Caribbean T-cell lymphoma/leukemia.

Authors:  S H Swerdlow; J A Habeshaw; A Z Rohatiner; T A Lister; A G Stansfeld
Journal:  Cancer       Date:  1984-08-15       Impact factor: 6.860

7.  Pathogenesis of hypercalcemia in lymphosarcoma cell leukemia. Role of an osteoclast activating factor-like substance and a mechanism of action for glucocorticoid therapy.

Authors:  G R Mundy; M E Rick; R Turcotte; M A Kowalski
Journal:  Am J Med       Date:  1978-10       Impact factor: 4.965

8.  Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera.

Authors:  Y Hinuma; K Nagata; M Hanaoka; M Nakai; T Matsumoto; K I Kinoshita; S Shirakawa; I Miyoshi
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

9.  Non-Hodgkin lymphoma of bone.

Authors:  E M Braunstein; S J White
Journal:  Radiology       Date:  1980-04       Impact factor: 11.105

  9 in total
  3 in total

1.  HTLV-1 Tax transgenic mice develop spontaneous osteolytic bone metastases prevented by osteoclast inhibition.

Authors:  Ling Gao; Hongju Deng; Haibo Zhao; Angela Hirbe; John Harding; Lee Ratner; Katherine Weilbaecher
Journal:  Blood       Date:  2005-08-23       Impact factor: 22.113

2.  Case report 429: Adult T-cell leukemia (ATL).

Authors:  J Aoki; I Yamamoto; M Hino; K Torizuka; T Uchiyama; H Uchino
Journal:  Skeletal Radiol       Date:  1987       Impact factor: 2.199

3.  Mouse model recapitulates the phenotypic heterogeneity of human adult T-cell leukemia/lymphoma in bone.

Authors:  Nicole A Kohart; Said M Elshafae; Wachirapan Supsahvad; Aylin Alasonyalilar-Demirer; Amanda R Panfil; Jingyu Xiang; Wessel P Dirksen; Deborah J Veis; Patrick L Green; Katherine N Weilbaecher; Thomas J Rosol
Journal:  J Bone Oncol       Date:  2019-08-20       Impact factor: 4.072

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.